Publications by authors named "Claudio Arrigoni"

Claim this Profile
N
Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors.
Shem Patyna, Claudio Arrigoni, Andrea Terron, Tae-Won Kim, Joyce K Heward

Toxicol Pathol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.
Patrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini, Paolo Cappella, Laura Gianellini, Claudio Arrigoni

Mol Cancer Ther· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis